Rein Therapeutics, Inc. Common Stock
RNTX • NASDAQ
Rein Therapeutics, Inc. Common Stock is a pharmaceutical preparations company trading on NASDAQ, led by CEO James Brian Windsor, with a market cap of $30.0M.
CEOJames Brian Windsor
Next Earnings
Upcoming earnings announcement for Rein Therapeutics, Inc. Common Stock
Date
Monday, April 6, 2026 (in 2 months)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q4 2025
EPS Estimate
-$0.22
Earnings History
Past 12 earnings reports for Rein Therapeutics, Inc. Common Stock
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 14, 2025 | Q3 2025 | -$0.21Est: -$0.24 | +12.5% | - | — |  10-Q |
| Aug 14, 2025 | Q2 2025 | -$0.28Est: -$0.22 | -27.3% | - | — | 10-Q |
| May 15, 2025 | Q1 2025 | -$0.25 | — | - | — | 10-Q |
| Apr 7, 2025 | Q4 2024 | -$1.89 | — | - | — | 10-K/A |
| Nov 14, 2024 | Q3 2024 | -$0.27Est: -$0.41 | +34.1% | - | — | 10-Q |
| Aug 14, 2024 | Q2 2024 | -$0.45Est: -$0.42 | -7.1% | - | — | 10-Q |
| May 15, 2024 | Q1 2024 | -$0.86 | — | - | — | 10-Q |
| Apr 15, 2024 | Q4 2023 | -$1.54 | — | - | — | 10-K/A |
| Oct 13, 2023 | Q3 2023 | -$0.40 | — | - | — | — |
| Aug 11, 2023 | Q2 2023 | -$0.39 | — | - | — | — |
| May 8, 2023 | Q1 2023 | -$1.05Est: -$0.86 | -22.1% | - | — | — |
| Mar 20, 2023 | Q4 2022 | -$1.02Est: -$1.36 | +25.0% | - | — | — |